The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Tag Archive for: FDA
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Upcoming Events
Notice
There are no upcoming events.
News & Recent Posts
- Jobs | Data Coordinator @ NYC Department of Homeless Services May 8, 2026
- Jobs | @ Albany Damien Center May 1, 2026
- Hepatitis Awareness Month 2026 April 13, 2026
- Hepatitis A, B and C in New York City: 2024 Annual Report March 30, 2026
- Advocacy | NYC Council Educational Briefing on Viral Hepatitis February 2026 March 20, 2026
